Cintas (CTAS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Fiscal 2024 revenue reached $9.6 billion, up 8.9% year-over-year, with Q4 revenue at $2.47 billion, an 8.2% increase and a new quarterly record.
Net income for fiscal 2024 was $1.57 billion, up 16.6%; Q4 net income was $414.3 million, up 19.7%.
Diluted EPS for fiscal 2024 was $15.15, up 16.6%; Q4 diluted EPS was $3.99, up 19.8%.
Strong cash generation enabled $530.9 million in dividends (up 18%) and $1 billion in share repurchases.
All operating segments performed strongly, with First Aid and Safety Services surpassing $1 billion in annual revenue for the first time.
Financial highlights
Fiscal 2024 gross margin was 48.8%, up from 47.3% in 2023; Q4 gross margin reached 49.2%.
Fiscal 2024 operating income rose 14.8% to $2.07 billion; Q4 operating income was $547.6 million, up 16.3%.
Fiscal 2024 operating margin was a record 21.6%; Q4 operating margin was 22.2%.
Net income margin for fiscal 2024 was 16.4%, up from 15.3% in 2023.
Cash flow from operations exceeded $2 billion for the first time; free cash flow was $1.67 billion.
Outlook and guidance
Fiscal 2025 revenue expected between $10.16 billion and $10.31 billion, a growth rate of 5.9%-7.4%.
Organic growth for 2025 projected at 6.4%-8%, adjusting for two fewer workdays.
Diluted EPS guidance for 2025 is $16.25-$16.75, representing 7.3%-10.6% growth.
Net interest expense expected to rise to $106 million due to higher variable rate debt.
Effective tax rate for 2025 expected to remain at 20.4%.
Latest events from Cintas
- Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 202615 Jul 2026 - Revenue and net income surged, margins expanded, and guidance was raised for the full year.CTAS
Q2 20259 Jul 2026 - Revenue and profit surged, margins expanded, and guidance was raised amid strong capital returns.CTAS
Q1 20259 Jul 2026 - Q1 revenue and net income rose 8.7%, with raised guidance and strong share repurchases.CTAS
Q1 20269 Jul 2026 - Q3 revenue and EPS surged, driving higher guidance and robust margin expansion.CTAS
Q3 20258 Jul 2026 - Record revenue, margin highs, and raised guidance driven by broad-based growth and strong retention.CTAS
Q2 20268 Jul 2026 - Q3 revenue up 8.9%, record margins, guidance raised, $5.5B UniFirst deal announced.CTAS
Q3 20267 Apr 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026